SCHEMBL23360685

SCHEMBL23360685

CC(C)(C)OC(=O)N1CCC(Nc2cccc3ccncc23)CC1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.53
CCNA2 P20248 1/20 0.52
CDK2 P24941 1/20 0.52
GPR119 Q8TDV5 6/20 0.50
ALDH1A1 P00352 2/20 0.50
NPC1 O15118 1/20 0.49
MAPT P10636 1/20 0.49
MAPK1 P28482 1/20 0.49
HTT P42858 1/20 0.49
RAB9A P51151 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ROCK2 O75116 4/20 0.47
ROCK1 Q13464 4/20 0.47
CNR1 P21554 1/20 0.47
BRD4 O60885 1/20 0.45
IDH1 O75874 1/20 0.45
IDH2 P48735 1/20 0.45
JAK1 P23458 1/20 0.44
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29863072 1.00 DYRK1A (0.53) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL5662572 0.92 ROCK2 (0.58) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL29862650 0.92 ROCK2 (0.58) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL23360441 0.88 DYRK1A (0.54) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL528598 0.86 ROCK2 (0.54) ROCK2ROCK1
SCHEMBL659539 0.86 ROCK2 (0.54) ROCK2ROCK1
SCHEMBL23359964 0.82 ALDH1A1 (0.51) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL30958681 0.82 ALDH1A1 (0.51) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL23360200 0.82 DYRK1A (0.50) DYRK1ACCNA2CDK2GPR119ALDH1A1
SCHEMBL29862731 0.82 DYRK1A (0.50) DYRK1ACCNA2CDK2GPR119ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4055014-B1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORP (KR) 2025-04-30 EP disclosed
US-11655235-B2 Pyrrolidine and piperidine compounds YUHAN CORPORATION (KR) 2023-05-23 US disclosed
EP-4055014-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS Yuhan Corporation (KR) 2022-09-14 EP disclosed
CN-114867719-A Pyrrolidine and piperidine compounds 柳韩洋行 2022-08-05 CN disclosed
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS YUHAN CORPORATION (KR) 2021-05-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11655235-B2 Pyrrolidine and piperidine compounds FAP, APC, VHL DYRK1A 4697/4885CCNA2 3851/4885CDK2 1830/4885
US-20210147386-A1 PYRROLIDINE AND PIPERIDINE COMPOUNDS FAP, APC, VHL DYRK1A 4697/4885CCNA2 3851/4885CDK2 1830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.